Vilanova i la Geltrú, Spain

Jorg Holenz

This inventor holds 1 USPTO granted patent. Top assignee: Laboratorios Del Dr. Esteve S.a.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jorg Holenz. Retrieved from https://idiyas.com/inventor/jorg-holenz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jorg Holenz: Innovator in Pharmaceutical Chemistry

Introduction

Jorg Holenz is a notable inventor based in Vilanova i la Geltrú, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of therapeutic agents. His work focuses on innovative compounds that have the potential to improve health outcomes.

Latest Patents

Jorg Holenz holds a patent for "Derivatives of pyrazoline, procedure for obtaining them and use thereof as therapeutic agents." This invention relates to derivatives of a specific general formula and their pharmaceutically acceptable salts. The derivatives are useful as anti-inflammatory and analgesic agents, showcasing their potential in therapeutic applications.

Career Highlights

Holenz is associated with Laboratorios Del Dr. Esteve S.A., where he has been instrumental in advancing research and development in pharmaceutical products. His expertise in creating novel compounds has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Jorg has collaborated with notable colleagues, including Mercedes Port De Pol and Mario Colombo Piñol. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Jorg Holenz's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his commitment to advancing therapeutic solutions. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…